Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(2)
Other(1)

Detailed Status

Completed2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

unknown133%
completed267%

Recent Activity

0 active trials
Showing 3 of 3
completednot_applicable

Triamcinolone Acetonide in Patients With Serous Pigment Epithelial Detachment

NCT04292756
unknownnot_applicable

Antiangiogenic Therapy of Choroidal Neovascularisation Associated With Central Chorioretinitis

NCT04245072
completednot_applicable

Genetic Study of Patients Suffering From Congenital Amaurosis of Leber or From an Early Severe Retinal Dystrophy

NCT00422721

Clinical Trials (3)

Showing 3 of 3 trials
NCT04292756Not Applicable

Triamcinolone Acetonide in Patients With Serous Pigment Epithelial Detachment

Completed
NCT04245072Not Applicable

Antiangiogenic Therapy of Choroidal Neovascularisation Associated With Central Chorioretinitis

Unknown
NCT00422721Not Applicable

Genetic Study of Patients Suffering From Congenital Amaurosis of Leber or From an Early Severe Retinal Dystrophy

Completed

All 3 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
3